TY - JOUR
T1 - Evaluation of advanced cooling therapy’s esophageal cooling device for core temperature control
AU - Naiman, Melissa
AU - Shanley, Patrick
AU - Garrett, Frank
AU - Kulstad, Erik
PY - 2016/5/3
Y1 - 2016/5/3
N2 - ABSTRACT: Managing core temperature is critical to patient outcomes in a wide range of clinical scenarios. Previous devices designed to perform temperature management required a trade-off between invasiveness and temperature modulation efficiency. The Esophageal Cooling Device, made by Advanced Cooling Therapy (Chicago, IL), was developed to optimize warming and cooling efficiency through an easy and low risk procedure that leverages heat transfer through convection and conduction. Clinical data from cardiac arrest, fever, and critical burn patients indicate that the Esophageal Cooling Device performs very well both in terms of temperature modulation (cooling rates of approximately 1.3°C/hour, warming of up to 0.5°C/hour) and maintaining temperature stability (variation around goal temperature ± 0.3°C). Physicians have reported that device performance is comparable to the performance of intravascular temperature management techniques and superior to the performance of surface devices, while avoiding the downsides associated with both.
AB - ABSTRACT: Managing core temperature is critical to patient outcomes in a wide range of clinical scenarios. Previous devices designed to perform temperature management required a trade-off between invasiveness and temperature modulation efficiency. The Esophageal Cooling Device, made by Advanced Cooling Therapy (Chicago, IL), was developed to optimize warming and cooling efficiency through an easy and low risk procedure that leverages heat transfer through convection and conduction. Clinical data from cardiac arrest, fever, and critical burn patients indicate that the Esophageal Cooling Device performs very well both in terms of temperature modulation (cooling rates of approximately 1.3°C/hour, warming of up to 0.5°C/hour) and maintaining temperature stability (variation around goal temperature ± 0.3°C). Physicians have reported that device performance is comparable to the performance of intravascular temperature management techniques and superior to the performance of surface devices, while avoiding the downsides associated with both.
KW - Targeted temperature management
KW - fever control
KW - mild therapeutic hypothermia
KW - operative normothermia
UR - http://www.scopus.com/inward/record.url?scp=84963533902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963533902&partnerID=8YFLogxK
U2 - 10.1080/17434440.2016.1174573
DO - 10.1080/17434440.2016.1174573
M3 - Article
C2 - 27043177
AN - SCOPUS:84963533902
SN - 1743-4440
VL - 13
SP - 423
EP - 433
JO - Expert review of medical devices
JF - Expert review of medical devices
IS - 5
ER -